AsOf

Recorded or changed on this day 2026-11-08

44,801–44,850 of 46,537 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -10,770,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -10,770,000 United States dollar, claim clm_0A5AAF6DC9F9 · ended · superseded by clm_C200AAD1B7D9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 27,423,300,000 United States dollar
Vertex Pharmaceuticals total assets: 27,423,300,000 United States dollar, claim clm_0B039E70EB86 · ended · superseded by clm_E8F64842EB2A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 719,692,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 719,692,000 United States dollar, claim clm_0B18EFEDD159 · ended · superseded by clm_DD9DC904D715 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 446,658,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 446,658,000 United States dollar, claim clm_0B1A1540D1B7 · ended · superseded by clm_704DCF1A9448 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 7,033,471,000 United States dollar
Vertex Pharmaceuticals total assets: 7,033,471,000 United States dollar, claim clm_0B97F438BFA4 · ended · superseded by clm_606AE4761405 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 9,171,500,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 9,171,500,000 United States dollar, claim clm_0BD6127815F8 · ended · superseded by clm_63A9B4EA0EFC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 114,424,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 114,424,000 United States dollar, claim clm_0CB375426AF0 · ended · superseded by clm_AFFDEC5591E2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 310,553,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 310,553,000 United States…, claim clm_0D1ACE4B2058 · ended · superseded by clm_75860C5404D3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 6,143,500,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 6,143,500,000 United States dollar, claim clm_0DE5C5FBB098 · ended · superseded by clm_40B40C0D43E5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 253,891,984 shares
Vertex Pharmaceuticals shares outstanding: 253,891,984 shares, claim clm_0E283F15F605 · ended · superseded by clm_D91AA7148A23 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 827,135,000 United States dollar
Vertex Pharmaceuticals total equity: 827,135,000 United States dollar, claim clm_0E4918D23EC7 · ended · superseded by clm_6AC662175277 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,548,982,000 United States dollar
Vertex Pharmaceuticals total assets: 2,548,982,000 United States dollar, claim clm_0E60C94FDAC7 · ended · superseded by clm_3FA9F1E3CCFF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · 207,360,000 United States dollar
Vertex Pharmaceuticals quarterly net income: 207,360,000 United States dollar, claim clm_0E72F2D69F41 · ended · superseded by clm_346AA350FC6D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 19,361,900,000 United States dollar
Vertex Pharmaceuticals total equity: 19,361,900,000 United States dollar, claim clm_0F975664C00F · ended · superseded by clm_DDD2C596A0EC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 253,460,924 shares
Vertex Pharmaceuticals shares outstanding: 253,460,924 shares, claim clm_10753153913F · ended · superseded by clm_41CC1CCC4C8A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,197,108,000 United States dollar
Vertex Pharmaceuticals total assets: 2,197,108,000 United States dollar, claim clm_1085DB3D0A82 · ended · superseded by clm_F96409BD070A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,487,906,000 United States dollar
Vertex Pharmaceuticals total assets: 2,487,906,000 United States dollar, claim clm_1114776585A3 · ended · superseded by clm_0E60C94FDAC7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 202,831,612 shares
Vertex Pharmaceuticals shares outstanding: 202,831,612 shares, claim clm_115794095037 · ended · superseded by clm_69DF2085CFCB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · -107,032,000 United States dollar
Vertex Pharmaceuticals net income: -107,032,000 United States dollar, claim clm_117D40256E77 · ended · superseded by clm_59D5E0CC1F00 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 894,964,000 United States dollar
Vertex Pharmaceuticals total equity: 894,964,000 United States dollar, claim clm_12232D5A6B98 · ended · superseded by clm_979E4CDDAA4B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 11,301,633,000 United States dollar
Vertex Pharmaceuticals total assets: 11,301,633,000 United States dollar, claim clm_12837A3657DA · ended · superseded by clm_C7952DDAD12A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 8,686,800,000 United States dollar
Vertex Pharmaceuticals total equity: 8,686,800,000 United States dollar, claim clm_12C888060D24 · ended · superseded by clm_A498CCC0EE53 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,493,200,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,493,200,000 United States dollar, claim clm_12CF2E7419A7 · ended · superseded by clm_25F0B0F08F89 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,584,329,000 United States dollar
Vertex Pharmaceuticals total assets: 2,584,329,000 United States dollar, claim clm_13FE3C35A2BF · ended · superseded by clm_4674F8E819AD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -438,288,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -438,288,000 United States dollar, claim clm_140090973306 · ended · superseded by clm_802A10BA2903 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Vertex Pharmaceuticals · agreement · Crinetics Pharmaceuticals, Inc.
Vertex Pharmaceuticals agreement: Crinetics Pharmaceuticals, Inc., claim clm_14EDB54D4A3B · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,204,280,000 United States dollar
Vertex Pharmaceuticals total assets: 2,204,280,000 United States dollar, claim clm_15FE4534F8E1 · ended · superseded by clm_A3EAB937180F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,759,288,000 United States dollar
Vertex Pharmaceuticals total assets: 2,759,288,000 United States dollar, claim clm_16575A0C10F3 · ended · superseded by clm_2B5B93D6737A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 1,075,006,000 United States dollar
Vertex Pharmaceuticals total equity: 1,075,006,000 United States dollar, claim clm_16DE270CBEB7 · ended · superseded by clm_33DE4ADFA95C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 5,239,200,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 5,239,200,000 United States dollar, claim clm_17107958B9E8 · ended · superseded by clm_7036AF53899D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 247,349,864 shares
Vertex Pharmaceuticals shares outstanding: 247,349,864 shares, claim clm_184409A3DE47 · ended · superseded by clm_AAFEE05A628C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly net income · -208,957,000 United States dollar
Vertex Pharmaceuticals quarterly net income: -208,957,000 United States dollar, claim clm_185D3E640F90 · ended · superseded by clm_ECF62E043F01 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 990,612,000 United States dollar
Vertex Pharmaceuticals total equity: 990,612,000 United States dollar, claim clm_19213C00D007 · ended · superseded by clm_0E4918D23EC7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 10,216,367,000 United States dollar
Vertex Pharmaceuticals total assets: 10,216,367,000 United States dollar, claim clm_194411381C8C · ended · superseded by clm_12837A3657DA · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 4,723,313,000 United States dollar
Vertex Pharmaceuticals total equity: 4,723,313,000 United States dollar, claim clm_19FEE797F4E7 · ended · superseded by clm_DD7CA9ADDF1C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · revenue · 1,527,042,000 United States dollar
Vertex Pharmaceuticals revenue: 1,527,042,000 United States dollar, claim clm_1A11D785AD34 · ended · superseded by clm_B995587F5A51 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly research and development · 339,490,000 United States dollar
Vertex Pharmaceuticals quarterly research and development: 339,490,000 United States…, claim clm_1A5BF9CE8A15 · ended · superseded by clm_6053DA9FFA3A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -326,043,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -326,043,000 United States dollar, claim clm_1A65A038D644 · ended · superseded by clm_A620E2C8FB71 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 257,035,443 shares
Vertex Pharmaceuticals shares outstanding: 257,035,443 shares, claim clm_1AA1A71F7141 · ended · superseded by clm_F6BD01886FBB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · net income · 3,322,000,000 United States dollar
Vertex Pharmaceuticals net income: 3,322,000,000 United States dollar, claim clm_1B7C3640D846 · ended · superseded by clm_DD75AE2A6FF1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total assets · 2,498,875,000 United States dollar
Vertex Pharmaceuticals total assets: 2,498,875,000 United States dollar, claim clm_1B7DAA0B3049 · ended · superseded by clm_1114776585A3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · shares outstanding · 258,307,816 shares
Vertex Pharmaceuticals shares outstanding: 258,307,816 shares, claim clm_1BAB99487696 · ended · superseded by clm_7CB6DBDB3720 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 605,866,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 605,866,000 United States dollar, claim clm_1C6CC599E968 · ended · superseded by clm_0B18EFEDD159 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · 1,054,512,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: 1,054,512,000 United States dollar, claim clm_1CB49C635F67 · ended · superseded by clm_2A24B9B7FC69 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 10,100,000,000 United States dollar
Vertex Pharmaceuticals total equity: 10,100,000,000 United States dollar, claim clm_1E5426FCEFF5 · ended · superseded by clm_318FD2D6E763 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 17,318,800,000 United States dollar
Vertex Pharmaceuticals total equity: 17,318,800,000 United States dollar, claim clm_1E5EC8CA7B8E · ended · superseded by clm_335F6E7CE9CE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly revenue · 2,770,200,000 United States dollar
Vertex Pharmaceuticals quarterly revenue: 2,770,200,000 United States dollar, claim clm_1EC0DE7E99A1 · ended · superseded by clm_9B7DD75E016B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · cash and equivalents · 870,543,000 United States dollar
Vertex Pharmaceuticals cash and equivalents: 870,543,000 United States dollar, claim clm_1EF267F21DD6 · ended · superseded by clm_D372DE4FDD99 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · quarterly operating income · -37,961,000 United States dollar
Vertex Pharmaceuticals quarterly operating income: -37,961,000 United States dollar, claim clm_1F15DBA70DE0 · ended · superseded by clm_1CB49C635F67 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Vertex Pharmaceuticals · total equity · 307,549,000 United States dollar
Vertex Pharmaceuticals total equity: 307,549,000 United States dollar, claim clm_1F567078AF69 · ended · superseded by clm_56187F563316 · 1 source (1 primary) · conf 0.95

What the statuses mean